185 related articles for article (PubMed ID: 26627008)
1. Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.
Ranjan A; Gupta P; Srivastava SK
Cancer Res; 2016 Feb; 76(4):877-90. PubMed ID: 26627008
[TBL] [Abstract][Full Text] [Related]
2. Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis.
Xue Q; Liu Z; Feng Z; Xu Y; Zuo W; Wang Q; Gao T; Zeng J; Hu X; Jia F; Zhu Y; Xia Y; Yu L
Biomed Pharmacother; 2020 Jan; 121():109598. PubMed ID: 31733572
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis.
Gupta N; Srivastava SK
Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071408
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis.
Wu L; Liu YY; Li ZX; Zhao Q; Wang X; Yu Y; Wang YY; Wang YQ; Luo F
Asian Pac J Cancer Prev; 2014; 15(1):489-94. PubMed ID: 24528079
[TBL] [Abstract][Full Text] [Related]
5. Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Ashraf-Uz-Zaman M; Sajib MS; Cucullo L; Mikelis CM; German NA
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3652-3657. PubMed ID: 30389290
[TBL] [Abstract][Full Text] [Related]
6. Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
Ranjan A; Srivastava SK
Oncotarget; 2017 May; 8(20):32960-32976. PubMed ID: 28380428
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
8. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
10. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
11. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
[TBL] [Abstract][Full Text] [Related]
12. Penfluridol overcomes paclitaxel resistance in metastatic breast cancer.
Gupta N; Gupta P; Srivastava SK
Sci Rep; 2019 Mar; 9(1):5066. PubMed ID: 30911062
[TBL] [Abstract][Full Text] [Related]
13. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent.
Tuan NM; Lee CH
Molecules; 2019 Oct; 24(20):. PubMed ID: 31614431
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
15. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
[TBL] [Abstract][Full Text] [Related]
16. Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis.
Ranjan A; Srivastava SK
Sci Rep; 2016 May; 6():26165. PubMed ID: 27189859
[TBL] [Abstract][Full Text] [Related]
17. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
[TBL] [Abstract][Full Text] [Related]
18. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
20. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]